Paper ยท 21889194
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Delmore JE and 23 others. Cell, 2011. Cited by 2,411 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Papers, record 21889194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21889194
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Drug Discovery | Major topic |
| Multiple Myeloma | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Animals | |
| Azepines | |
| Benzodiazepines | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Humans | |
| Mice | |
| Nuclear Proteins | |
| Protein Structure, Tertiary | |
| Transcriptional Activation | |
| Triazoles |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01CA46455 | NCI NIH HHS | United States | PubMed | PubMed | |
| R01 CA136671 | NCI NIH HHS | United States | R01CA136671 | PubMed and NIH | NIH RePORTER |
| R01 AG020686 | NIA NIH HHS | United States | R01AG020686 | PubMed and NIH | NIH RePORTER |
| R01 CA050947 | NCI NIH HHS | United States | R01CA050947 | PubMed and NIH | NIH RePORTER |
| K08CA128972 | NCI NIH HHS | United States | K08CA128972 | PubMed and NIH | NIH RePORTER |
| R01 CA133966 | NCI NIH HHS | United States | R01CA133966 | PubMed and NIH | NIH RePORTER |
| Wellcome Trust | United Kingdom | PubMed | PubMed | ||
| R01CA050947 | NCI NIH HHS | United States | R01CA050947 | PubMed and NIH | NIH RePORTER |
| R01HG002668 | NHGRI NIH HHS | United States | R01HG002668 | PubMed and NIH | NIH RePORTER |
| K08 CA128972 | NCI NIH HHS | United States | K08CA128972 | PubMed and NIH | NIH RePORTER |
1 to 10 of 11
See all 11 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 21,941,280 | Targeting MYC? You BET. | https://conductscience.org/library/papers/21941280 | PubMed |
| Comment in | 21,959,283 | Targeting MYC? You BET. | https://conductscience.org/library/papers/21959283 | PubMed |
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,664,422 | Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17664422 | PubMed |
| 2 | 3,011,271 | Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. | Cell | 1986 | https://conductscience.org/library/papers/3011271 | PubMed |
| 3 | 17,690,245 | Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17690245 | PubMed |
| 4 | 8,425,220 | Oncogenic activity of the c-Myc protein requires dimerization with Max. | Cell | 1993 | https://conductscience.org/library/papers/8425220 | PubMed |
| 5 | 19,549,893 | Evaluation of the 8q24 prostate cancer risk locus and MYC expression. | Cancer Res | 2009 | https://conductscience.org/library/papers/19549893 | PubMed |
| 6 | 11,823,794 | Sibling rivalry in the E2F family. | Nat Rev Mol Cell Biol | 2002 | https://conductscience.org/library/papers/11823794 | PubMed |
| 7 | 6,413,865 | Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene. | Nature | 1983 | https://conductscience.org/library/papers/6413865 | PubMed |
| 8 | 19,861,459 | MYC-induced cancer cell energy metabolism and therapeutic opportunities. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19861459 | PubMed |
| 9 | 12,200,383 | A molecular compendium of genes expressed in multiple myeloma. | Blood | 2002 | https://conductscience.org/library/papers/12200383 | PubMed |
| 10 | 15,902,208 | An inhibitor of Bcl-2 family proteins induces regression of solid tumours. | Nature | 2005 | https://conductscience.org/library/papers/15902208 | PubMed |
1 to 10 of 63
See all 63 referencesCited by1,766
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,411 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,959,345 | Disease-guided targeted protein degradation and clearance: matching strategies to pathological protein states. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42959345 | PubMed |
| 42,950,026 | FOSL1-associated condensates modulate superenhancer-mediated selected IL-1 family gene activation in psoriasis. | Sci Adv | 2026 | https://conductscience.org/library/papers/42950026 | PubMed |
| 42,888,198 | BUB signaling in cancer and molecular insights into targeted therapies. | Commun Biol | 2026 | https://conductscience.org/library/papers/42888198 | PubMed |
| 42,875,775 | RAS pathway mutations orchestrate chromatin reconfiguration and transcriptional rewiring in colorectal cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42875775 | PubMed |
| 42,840,296 | Protein arginine methylation in transcription and epigenetic regulation. | Front Epigenet Epigenom | 2023 | https://conductscience.org/library/papers/42840296 | PubMed |
| 42,798,998 | Fragment-Based Discovery of BRD4-BD2 Selective Binders: Biophysical Validation and Structural Insights for Domain-Selective Inhibitor Design. | ACS Omega | 2026 | https://conductscience.org/library/papers/42798998 | PubMed |
| 42,778,564 | Unc-51 like kinase 3 (ULK3) contributes to autophagy and cell survival in multiple myeloma. | Nat Commun | 2026 | https://conductscience.org/library/papers/42778564 | PubMed |
| 42,603,101 | Epigenetic reprogramming of lineage switching in cancer. | FEBS Lett | 2026 | https://conductscience.org/library/papers/42603101 | PubMed |
| 42,558,596 | Cell competition within breast tumor microenvironment: emerging role of cancer stem cells and immune cells in tumor progression and therapeutic implications. | Front Oncol | 2026 | https://conductscience.org/library/papers/42558596 | PubMed |
| 42,512,290 | Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512290 | PubMed |
1 to 10 of 1,766
See all 1,766 cited byGenes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BRD2 | 6,046 | PubTator's text mining | https://conductscience.org/library/genes/6046 | NCBI Gene |
| BRD3 | 8,019 | PubTator's text mining | https://conductscience.org/library/genes/8019 | NCBI Gene |
| BRD4 | 23,476 | PubTator's text mining | https://conductscience.org/library/genes/23476 | NCBI Gene |
| BRDT | 676 | PubTator's text mining | https://conductscience.org/library/genes/676 | NCBI Gene |
| DNER | 92,737 | PubTator's text mining | https://conductscience.org/library/genes/92737 | NCBI Gene |
| E2F1 | 1,869 | PubTator's text mining | https://conductscience.org/library/genes/1869 | NCBI Gene |
| GAPDH | 2,597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| HSF1 | 3,297 | PubTator's text mining | https://conductscience.org/library/genes/3297 | NCBI Gene |
1 to 10 of 22
See all 22 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE31365 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21889194
GET https://conductscience.org/api/papers/v1/21889194/authors?page=2